Mark McCarty of Medical Device Daily provides an excellent overview of the fraud and compliance panel discussion at the MDMA Annual Meeting in his article entitled, "Scrutiny of device industry unlikely to ebb anytime soon."   

 

"... The situation constitutes the perfect storm, [Attorney Michael] Sullivan noted. "State and federal revenue is on the downturn," so "there's no question there's a motivated buyer out there on the enforcement side.

"Mike Bell, president of the compliance consultancy R-Squared (Princeton, New Jersey), said he would offer some relief from the gloom and doom, but seemed to brush aside industry complaints with the observation, "at this date and time, it's almost inexcusable for some of these things to happen."  Read more here.